Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Lenvatinib Plus Pembrolizumab In Patients With Immune Checkpoint Inhibitor Naïve Metastatic Uveal Melanoma

Providence Health & Services · 2022
ClinicalTrials.gov · Datasets · License: Public Domain · 2022
Open Source ↗
melanomapembrolizumab
melanoma, uveal, melanoma, uveal, pembrolizumab, phase 2, lenvatinib, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 803882
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.